The absence of FOXM1 corresponds to lowered VEGF in vitro, and, in mouse experiments, glioma cells with FOXM1 inhibited were found to have lower VEGF than their counterparts [58]. The gene discussed is FOXM1; the disease is central nervous system cancer.